The Brainreader story
Brainreader develops advanced healthcare-grade AI based decision support software. Our technology analyzes medical imaging to provide one of the most comprehensive solutions for flagging acute abnormalities across the brain, helping healthcare professionals prioritize life threatening cases and expedite patient care.
Facts about Brainreader:
- Founded in 2011
- CE marked in 2013
- FDA cleared in 2015
- HIPAA compliant
- Cover all states in the US with Sales and Support
Brainreader was founded in 2011 by scientist Jamila Ahdidan, PhD with the goal of using AI to reinvent the medical diagnostic paradigm and in the process, improve treatment outcomes for patients living with neurodegenerative diseases. While completing her PhD, Jamila witnessed firsthand the challenges faced by neurologists and other specialists in the early diagnosis and treatment of neurodegenerative diseases, as well as the poor patient outcomes that resulted.
It was at this intersection that Neuroreader® was created.
Today, Brainreader is one of the leading global players within the field of brain volumetrics.
Physicians are increasingly becoming aware of how the brain volumetric data from the Neuroreader® Report can assist in understanding the full picture, resulting in improved brain health diagnoses.
Brainreader Founder, Jamila Ahdidan, PhD
